Johnson & Johnson Consumer Companies

Corporate brand

Johnson & Johnson Consumer Companies was the former consumer-health portfolio of Johnson & Johnson, encompassing household brands in baby care, over-the-counter medicines, skin care, oral care and wound care before its separation into Kenvue.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Johnson & Johnson Consumer Companies was the consumer-health side of Johnson & Johnson, the American healthcare group founded in 1886. It was not a single consumer product line so much as a portfolio of operating businesses and trademarks marketed under the Johnson & Johnson corporate umbrella. Its products reached consumers through pharmacies, supermarkets, mass merchants, healthcare distributors and, increasingly, e-commerce channels. The portfolio became internationally recognizable through brands such as Johnson’s baby-care products, Band-Aid adhesive bandages, Tylenol pain relievers, Listerine oral-care products, Neutrogena skin care and Aveeno skin and body care. Depending on market and period, the wider consumer organization also included brands such as Motrin, Rogaine, Nicorette, OGX, Maui Moisture and Dr.Ci:Labo. Product ownership and distribution changed over time through acquisitions, divestitures, licensing arrangements and regional portfolio decisions, so the precise brand list varied by reporting period and country. The division’s positioning combined Johnson & Johnson’s medical and scientific heritage with everyday convenience. Baby products emphasized gentleness, care and parental trust; over-the-counter medicines emphasized recognizable efficacy and responsible use; wound-care products focused on accessible first aid; and skin, hair and oral-care lines competed through formulation, dermatological or dental associations, packaging and broad retail availability. Marketing commonly used television, print, pharmacy promotion, digital media, social content, influencers and educational material. The company also developed audience-specific products and messages for parents, people with sensitive skin, families seeking self-care products and consumers with particular wellness concerns. The consumer business was strategically important because its brands were familiar to households worldwide, but Johnson & Johnson increasingly focused corporate resources on prescription medicines and medical technology. In November 2021, the company announced plans to separate its consumer-health business into a new company. The successor was named Kenvue in 2022. Kenvue launched an initial public offering on the New York Stock Exchange in May 2023 under the ticker KVUE, while Johnson & Johnson initially retained a large majority stake. An exchange offer later reduced Johnson & Johnson’s ownership to a minority position, and Johnson & Johnson subsequently sold its remaining Kenvue stake. As a result, Johnson & Johnson Consumer Companies is best treated as a historical portfolio and predecessor business rather than an active standalone brand. The consumer brands continue under Kenvue and other owners where portfolios have changed.

History

Johnson & Johnson’s consumer-health activities developed within the broader history of the Johnson & Johnson healthcare group, which began in 1886 in the United States. The company’s consumer identity was built around products that connected professional healthcare knowledge with routine household care. Baby products, first-aid supplies and nonprescription medicines made the corporate name familiar beyond hospitals and pharmacies, while skin, oral and hair-care acquisitions broadened the portfolio. The organization operated through a decentralized collection of businesses rather than as one monolithic product company. This structure allowed individual brands to maintain distinct identities and marketing programs while benefiting from Johnson & Johnson’s research, regulatory capabilities, distribution scale and reputation. The portfolio addressed several consumer-health occasions: caring for infants, treating common pain and fever, cleaning and protecting minor wounds, maintaining oral hygiene, managing skin conditions and purchasing personal-care products. Over the decades, acquisitions strengthened the consumer medicines and personal-care portfolio. The acquisition of McNeil Laboratories supported the company’s position in consumer medicines, while the 2006 purchase of Pfizer’s consumer-health business added important brands and scale, including products associated with Listerine and other self-care categories. Brand ownership and product composition nevertheless varied by country and period, and some businesses were later sold or reorganized. Marketing relied on the emotional associations of family care as well as functional claims about safety, efficacy and convenience. Baby-care advertising sought to reassure parents; Band-Aid communications made first aid approachable; Tylenol and Motrin addressed everyday pain and fever; and dermatological brands such as Neutrogena and Aveeno used skin-science and sensitivity-related positioning. The group used conventional mass media alongside pharmacy activity, educational content, digital advertising, influencers and social video. Campaign activity also included mobile advertising experiments using audio ads, SMS and mobile websites, as well as newer social programs designed for platforms such as TikTok and Instagram Reels. By the early 2020s, Johnson & Johnson was placing greater strategic emphasis on innovative medicines and medical technology. In November 2021 it announced that the consumer-health activities would be separated into a new publicly traded company. The new entity was named Kenvue in 2022 and included many of the portfolio’s best-known brands. Kenvue completed its IPO on the New York Stock Exchange in May 2023. Johnson & Johnson initially retained majority ownership, then reduced its stake through an exchange offer and later disposed of its remaining shares. The transaction ended Johnson & Johnson Consumer Companies as a current operating division of the parent, although many of its brands remain active under Kenvue.

2023
Kenvue IPO and separation
[3]Johnson & Johnson Consumer Health Spinoff and Kenvue IPOcnbc.com
Kenvue completed its IPO on the New York Stock Exchange under KVUE, followed by further ownership reduction by Johnson & Johnson.
2022
Kenvue name unveiled
[4]Johnson & Johnson readies IPO for Kenvue consumer health businesscosmeticsbusiness.com
The planned standalone consumer-health company was named Kenvue and presented as the future home of many Johnson & Johnson consumer brands.
2021
Separation plan announced
[10]Separation plan announcedforex.com
Johnson & Johnson announced that it would separate its consumer-health business into a new company.
2006
Acquisition of Pfizer’s consumer-health business
[9]Cilag joins the Johnson & Johnson familyhistoryoasis.com
Johnson & Johnson acquired Pfizer’s consumer-health business, significantly expanding its international self-care and personal-health portfolio.
1960
Cilag joins the Johnson & Johnson family
[9]Cilag joins the Johnson & Johnson familyhistoryoasis.com
The incorporation of Swiss pharmaceutical company Cilag expanded Johnson & Johnson’s European presence and broader healthcare platform.
1886
Johnson & Johnson is founded
[1]Johnson & Johnson corporate websitejnj.com
The founding of Johnson & Johnson established the corporate healthcare group from which its later consumer businesses developed.

Products and positioning

A trusted, science-informed consumer-health portfolio offering everyday care, self-medication, personal hygiene and family wellness products through global retail and healthcare channels.

Baby care
Johnson’s
A baby-care portfolio associated with shampoos, washes, lotions and related products for infants and families. Its long-standing positioning centers on mildness, cleanliness and parental reassurance, while later product development and packaging addressed ingredient preferences and sensitive-skin concerns. The brand was among the most recognizable consumer assets transferred to Kenvue.
Wound care
Band-Aid
An adhesive-bandage brand used for minor cuts, scrapes and everyday first aid. The line includes multiple formats and designs intended for different wound-care needs and consumer preferences. Its marketing helped make basic wound protection an ordinary household purchase rather than a product limited to clinical settings.
Over-the-counter medicine
Tylenol
A major nonprescription analgesic and fever-reducer brand marketed in multiple formulations and dosage forms, subject to country-specific regulation. Tylenol became one of the central consumer-health assets associated with Johnson & Johnson and was included in the portfolio transferred to Kenvue.
Oral care
Listerine
An oral-care brand centered on mouthwash and related hygiene products. It competes through breath-freshening, plaque and germ-control propositions that vary by formulation and market. Listerine was part of the expanded consumer-health portfolio and became a Kenvue brand following the separation.
Skin care
Neutrogena
A skin-care brand associated with dermatologist-oriented products for cleansing, moisturizing, acne care, sun protection and other personal-care needs. Its positioning has generally emphasized formulations, skin science and suitability for varied skin concerns. Neutrogena was included among the principal brands moved into Kenvue.
Skin and body care
Aveeno
A skin and body-care brand known for products positioned around soothing, moisturizing and sensitive-skin care. Its portfolio includes body washes, lotions and related products, with communications often highlighting ingredient and dermatological associations. Aveeno, including Aveeno Baby products, became part of Kenvue’s brand portfolio.
Over-the-counter medicine
Motrin
An over-the-counter pain-relief brand marketed in formulations for common aches, pain and fever. It was one of the consumer brands used in Johnson & Johnson’s retail and digital marketing activities and was subsequently included in the consumer-health portfolio separated into Kenvue.
Hair care
OGX and Maui Moisture
Hair-care brands included in the consumer portfolio and featured in later social-content programs. They address cleansing, conditioning and styling-related consumer needs through differentiated ingredients, textures, fragrances and packaging. Their ownership and portfolio status should be checked by market because consumer-brand arrangements can change after the separation.

Marketing campaigns

BabyCenter partnership
International and market-specific digital channels
Johnson & Johnson used BabyCenter-related marketing activity to reach parents and promote infant-care products in a context centered on pregnancy, parenting and child development.
Outcome. The available reference material describes the partnership as a consumer-marketing effort but does not provide independently verifiable performance results.
Source
Multichannel mobile campaign
United States
A Johnson & Johnson mobile campaign used in-call audio advertising, SMS and mobile web experiences. Consumers heard a call to action during selected calls and could press a key to opt in, allowing the campaign to connect mass-reach audio placements with mobile engagement.
Outcome. The cited report describes the mechanics and youth-oriented targeting but does not establish campaign sales or engagement results.
Source
Consumer-brand social content program
Digital and social markets
Johnson & Johnson worked with a social-content agency to create recurring photography, short-form video, stop motion, illustrations, GIFs and paid-social assets for Tylenol, Motrin, Aveeno Baby, Johnson’s, Band-Aid, OGX and Maui Moisture.
Outcome. The agency reported improved engagement and refreshed digital presence, but the available material does not provide audited performance figures.
Source
Baby-care packaging and ingredient refresh
United States and other consumer markets
A reported revitalization initiative updated baby-product packaging, removed certain chemical dyes and emphasized more natural ingredients. One visible change was making the shampoo clear while retaining a familiar golden visual cue through the bottle design.
Outcome. The initiative was presented as an effort to modernize the baby-care business and rebuild relevance with contemporary parents.
Source

Brand decisions

2023
Launch Kenvue IPOM&A
Background
The separation required a public-market transaction to establish Kenvue as an independently investable consumer-health company.
Action taken
Kenvue priced its IPO at $22 per share and began trading on the New York Stock Exchange under KVUE.
Aftermath
Johnson & Johnson initially remained the majority shareholder, later reduced its stake through an exchange offer and ultimately sold its remaining interest.
IPO offer price. 22 USD per share (May 2023)
Source
2022
Create the Kenvue corporate identityStrategy
Background
The future standalone company required a distinct corporate name and identity while retaining a portfolio of familiar consumer brands.
Action taken
Johnson & Johnson unveiled the Kenvue name for the consumer-health business.
Aftermath
Kenvue became the operating identity used for the consumer portfolio and subsequently listed on the New York Stock Exchange.
Source
2021
Separate the consumer-health businessStrategy
Background
Johnson & Johnson concluded that a standalone consumer-health company would allow the parent to focus more closely on innovative medicines and medical technology while giving the consumer brands a dedicated operating structure.
Action taken
The company announced a planned separation of its consumer-health activities into a new publicly traded company.
Aftermath
The planned successor was named Kenvue in 2022 and proceeded toward an IPO and full separation.
Source

Sources11 sources

Cite this profile: Cite the canonical profile. /brand-wiki/johnson-and-johnson-consumer-companies · Editorial policy · How profiles are compiled